Antagonistic Anti-urokinase Plasminogen Activator Receptor (uPAR) Antibodies Significantly Inhibit uPAR-mediated Cellular Signaling and Migration

uPAR mediates anticancer activity of PEDF

(2010) Crispin R. Dass et al.   CANCER BIOLOGY & THERAPY

The urokinase receptor as an entertainer of signal transduction

(2009) Silvia D'Alessio   Frontiers in Bioscience-Landmark

Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited

(2009) Farideh Sabeh et al.   JOURNAL OF CELL BIOLOGY

Integrins and cell-fate determination

(2009) C. H. Streuli   JOURNAL OF CELL SCIENCE

LRP1 regulates remodeling of the extracellular matrix by fibroblasts

(2009) Alban Gaultier et al.   MATRIX BIOLOGY

Computer Aided Identification of Small Molecules Disrupting uPAR/α5β1- Integrin Interaction: A New Paradigm for Metastasis Prevention

(2009) Pratima Chaurasia et al.   PLoS One

Evolving role of uPA/uPAR system in human cancers

(2008) Kathleen Dass et al.   CANCER TREATMENT REVIEWS

Urokinase Plasminogen Activator Receptor Choreographs Multiple Ligand Interactions: Implications for Tumor Progression and Therapy

(2008) A. P. Mazar   CLINICAL CANCER RESEARCH

Endo180 expression with cofunctional partners MT1-MMP and uPAR–uPA is correlated with prostate cancer progression

(2008) Giolanta Kogianni et al.   EUROPEAN JOURNAL OF CANCER

Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with  1 integrins

(2008) C.-H. Tang et al.   JOURNAL OF CELL SCIENCE

Peptides and Small Molecules Targeting the Plasminogen Activation System: Towards Prophylactic Anti-Metastasis Drugs for Breast Cancer

(2008) Joel Tyndall et al.   Recent Patents on Anti-Cancer Drug Discovery